Urology.
The overarching principle throughout the benign prostatic hyperplasia guideline is that patient assessment of symptoms should guide evaluation and therapy. Opinions on prostate cancer run a wide gamut. The treatment of metastatic renal cell carcinoma with immunologic therapies continues to show promise.